DNM1L was divided into high and low-expression groups for GSEA using the median expression of DNM1L as the criterion to explore the molecular mechanism of DNM1L in GC, and 11 pathways were enriched in the HALLMARK set. Here, DNM1L is linked to gastric cancer.